201 related articles for article (PubMed ID: 9416938)
1. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Guazzi M; Melzi G; Agostoni P
Am J Cardiol; 1997 Dec; 80(12):1572-6. PubMed ID: 9416938
[TBL] [Abstract][Full Text] [Related]
2. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
3. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
Guazzi M; Marenzi G; Alimento M; Contini M; Agostoni P
Circulation; 1997 Apr; 95(7):1930-6. PubMed ID: 9107182
[TBL] [Abstract][Full Text] [Related]
4. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure.
Guazzi M; Palermo P; Pontone G; Susini F; Agostoni P
Am J Cardiol; 1999 Nov; 84(9):1038-43. PubMed ID: 10569660
[TBL] [Abstract][Full Text] [Related]
5. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors.
Guazzi M; Pontone G; Agostoni P
Am Heart J; 1999 Aug; 138(2 Pt 1):254-60. PubMed ID: 10426836
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
[TBL] [Abstract][Full Text] [Related]
7. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
Nawarskas JJ; Townsend RR; Cirigliano MD; Spinler SA
Am J Hypertens; 1999 Aug; 12(8 Pt 1):784-9. PubMed ID: 10480471
[TBL] [Abstract][Full Text] [Related]
8. Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failure.
Guazzi M; Agostoni P; Guazzi MD
J Am Coll Cardiol; 2001 Feb; 37(2):398-406. PubMed ID: 11216953
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Kitaoka H; Takata J; Hitomi N; Furuno T; Seo H; Chikamori T; Doi YL
Am J Cardiol; 2000 Mar; 85(5):658-60, A10. PubMed ID: 11078286
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
13. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Vizir VA; Berezin AE
Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction.
Akbulut T; Akgöz H; Dayi SU; Celik SE; Gürkan U; Tayyareci G
Angiology; 2006; 57(2):181-6. PubMed ID: 16518525
[TBL] [Abstract][Full Text] [Related]
16. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
Vizir VA; Berezin AE
Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
Guazzi M; Agostoni P
Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
20. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Davie AP; Dargie HJ; McMurray JJ
Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
